Cargando…

Specific Point-of-Care Testing of Coagulation in Patients Treated with Dabigatran

Background and Purpose Accurate and rapid assessment of coagulation status is necessary to guide thrombolysis or reversal of anticoagulation in stroke patients, but commercially available point-of-care (POC) assays are not suited for coagulation testing in patients treated with direct oral anticoag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Härtig, Florian, Birschmann, Ingvild, Peter, Andreas, Ebner, Matthias, Spencer, Charlotte, Gramlich, Michael, Richter, Hardy, Kuhn, Joachim, Lehmann, Rainer, Blumenstock, Gunnar, Zuern, Christine S., Ziemann, Ulf, Poli, Sven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180376/ https://www.ncbi.nlm.nih.gov/pubmed/33469905 http://dx.doi.org/10.1055/s-0040-1721775

Ejemplares similares

Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants
por: Ebner, Matthias, et al.
Publicado: (2017)

Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis
por: Ebner, Matthias, et al.
Publicado: (2018)

Point-of-care testing of coagulation in patients treated with edoxaban
por: Härtig, Florian, et al.
Publicado: (2020)

Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban
por: Härtig, Florian, et al.
Publicado: (2021)

UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and Its Comparison with Functional Assays
por: Kuhn, Joachim, et al.
Publicado: (2015)

Closure or medical therapy of patent foramen ovale in cryptogenic stroke: prospective case series
por: Poli, Sven, et al.
Publicado: (2021)

Deceleration capacity for rapid risk stratification in patients suffering from acute ischemic stroke: A prospective exploratory pilot study
por: Duckheim, Martin, et al.
Publicado: (2021)

In Vitro Selection of Specific DNA Aptamers Against the Anti-Coagulant Dabigatran Etexilate
por: Aljohani, Maher M., et al.
Publicado: (2018)

Effects of dabigatran and rivaroxaban on stroke severity according to the results of routine coagulation tests
por: Cho, Han-Jin, et al.
Publicado: (2020)

Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits
por: Yin, Lu, et al.
Publicado: (2022)

Multiple Autoimmune Syndromes Including Acute Disseminated Encephalomyelitis, Myasthenia Gravis, and Thyroiditis Following Messenger Ribonucleic Acid-Based COVID-19 Vaccination: A Case Report
por: Poli, Khouloud, et al.
Publicado: (2022)

The Sysmex CS-5100 coagulation analyzer offers comparable analytical performance and excellent throughput capabilities
por: Flieder, T., et al.
Publicado: (2016)

The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing
por: Kleber, Christian, et al.
Publicado: (2022)

Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran
por: Kim, Jong-Min, et al.
Publicado: (2022)

Pharmacokinetics of idarucizumab and its target dabigatran in patients requiring urgent reversal of the anticoagulant effect of dabigatran
por: Glund, Stephan, et al.
Publicado: (2019)

Electrochemical Disposable Biosensor to Monitor Dabigatran in Point-of-Care Anticoagulation Therapy
por: Mruthunjaya, Ashwin K. V., et al.
Publicado: (2023)

The Dabigatran debate
por: Kaba, Riyaz A, et al.
Publicado: (2014)

Routine Coagulation Tests in Patients With Nonvalvular Atrial Fibrillation Under Dabigatran and Rivaroxaban Therapy: An Affordable and Reliable Strategy?
por: Silva, Vanessa M., et al.
Publicado: (2019)

Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation
por: Henskens, Yvonne M. C., et al.
Publicado: (2018)

Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials
por: Mitchell, Lesley G., et al.
Publicado: (2022)

Intravenous thrombolysis in acute central retinal artery occlusion – A prospective interventional case series
por: Schultheiss, Maximilian, et al.
Publicado: (2018)

The Discovery of Dabigatran Etexilate
por: van Ryn, Joanne, et al.
Publicado: (2013)

Dabigatran and apolipoprotein B
por: ten Cate, Hugo
Publicado: (2016)

The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination
por: Glund, Stephan, et al.
Publicado: (2018)

Renal function estimations and dose recommendations for dabigatran, gabapentin and valaciclovir: a data simulation study focused on the elderly
por: Helldén, Anders, et al.
Publicado: (2013)

Point-of-Care Diagnostics in Coagulation Management
por: Sahli, Sebastian D., et al.
Publicado: (2020)

Cost of dabigatran for atrial fibrillation
por: Gage, Brian F
Publicado: (2011)

Dabigatran etexilate tetrahydrate
por: Liu, Hong-Qiang, et al.
Publicado: (2012)

Pharmacometric Characterization of Dabigatran Hemodialysis
por: Liesenfeld, Karl-Heinz, et al.
Publicado: (2013)

Dabigatran for left atrial thrombus
por: Morita, Sae, et al.
Publicado: (2013)

Promise and challenges of anticoagulation with dabigatran
por: Verma, Ashish, et al.
Publicado: (2012)

Dabigatran Associated Leukocytoclastic Vasculitis
por: Potolidis, Evangelos, et al.
Publicado: (2015)

Interstitial pneumonia caused by dabigatran
por: Yanagihara, Toyoshi, et al.
Publicado: (2017)

Possible renoprotective effects of dabigatran
por: Karahan, Oğuz
Publicado: (2015)

Bilateral Pulmonary Emboli on Dabigatran
por: Clark, Emily, et al.
Publicado: (2021)

Recurrent Acute Disseminated Encephalomyelitis (ADEM) after COVID-19-vaccination and after subsequent COVID-19-infection: A case report (part II)
por: Poli, Khouloud, et al.
Publicado: (2023)

Assessment of Haemostasis in Disseminated Intravascular Coagulation by Use of Point-of-Care Assays and Routine Coagulation Tests, in Critically Ill Patients; A Prospective Observational Study
por: Kander, Thomas, et al.
Publicado: (2016)

Cardiac Myxoma and Cerebrovascular Events: A Retrospective Cohort Study
por: Stefanou, Maria-Ioanna, et al.
Publicado: (2018)

A System for Continuous Pre- to Post-reperfusion Intra-carotid Cold Infusion for Selective Brain Hypothermia in Rodent StrokeModels
por: Wang, Yi, et al.
Publicado: (2020)

FREEZING POINTS OF ANTI-COAGULANT SALT SOLUTIONS
por: Hitchcock, David I., et al.
Publicado: (1935)

Cannot write session to /tmp/vufind_sessions/sess_ls1i1gthmrt9qof3kjafprgsli